SS-31 is a novel peptide that has shown potential in reducing oxidative stress and improving mitochondrial function in various disease models. It has been studied for its potential therapeutic benefits in conditions such as heart failure, neurodegenerative diseases, and ischemia-reperfusion injury.

Reviews and clinical notes will be available after checkout flow is implemented.